Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minneapolis Clinic of Neurology (MCN) is one of the largest independent, physician-owned neurology practices in the United States, established in 1955. The clinic provides comprehensive diagnostic and treatment services for a wide range of adult and pediatric neurological conditions, including epilepsy, multiple sclerosis, and movement disorders. MCN operates several full-service clinics across the Minneapolis-St. Paul metropolitan area, featuring advanced on-site diagnostics such as high-field MRI, EEG, and EMG. Beyond clinical practice, the organization maintains a dedicated clinical research department that collaborates with global pharmaceutical companies to conduct Phase II through IV clinical trials. Their multidisciplinary approach integrates neurology, neuropsychology, and sleep medicine to deliver specialized patient care. The clinic is recognized for its expertise in complex neurological management and its contribution to advancing neurological therapies through research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Minneapolis Clinic of Neurology.